Transenterix (TRXC) Trading -1.2% Higher

Shares of Transenterix Inc (NYSEAMERICAN:TRXC) traded up 1.2% during mid-day trading on Tuesday . The company traded as high as $1.89 and last traded at $1.64. 1,371,207 shares were traded during mid-day trading, a decline of 46% from the average session volume of 2,518,821 shares. The stock had previously closed at $1.66.

A number of analysts have issued reports on the stock. BTIG Research reiterated a “hold” rating on shares of Transenterix in a research note on Monday, December 18th. Zacks Investment Research cut shares of Transenterix from a “hold” rating to a “sell” rating in a research note on Thursday, January 11th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $2.61.

How to Become a New Pot Stock Millionaire

The firm has a market capitalization of $354.65, a P/E ratio of -1.84 and a beta of 2.12.

Institutional investors have recently modified their holdings of the company. Ladenburg Thalmann Financial Services Inc. increased its position in Transenterix by 87.8% during the third quarter. Ladenburg Thalmann Financial Services Inc. now owns 79,150 shares of the medical instruments supplier’s stock worth $113,000 after acquiring an additional 37,000 shares during the period. Virtu Financial LLC bought a new position in Transenterix during the fourth quarter worth $109,000. Bank of New York Mellon Corp increased its position in Transenterix by 94.0% during the fourth quarter. Bank of New York Mellon Corp now owns 119,584 shares of the medical instruments supplier’s stock worth $231,000 after acquiring an additional 57,944 shares during the period. Raymond James Financial Services Advisors Inc. bought a new position in Transenterix during the fourth quarter worth $113,000. Finally, Iguana Healthcare Management LLC bought a new position in Transenterix during the fourth quarter worth $241,000.

ILLEGAL ACTIVITY NOTICE: “Transenterix (TRXC) Trading -1.2% Higher” was first published by Stock Observer and is owned by of Stock Observer. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at https://www.thestockobserver.com/2018/03/20/transenterix-trxc-trading-1-2-higher.html.

Transenterix Company Profile

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.

Receive News & Ratings for Transenterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply